Inventor · disambiguated record
James E. Bradner
Also filed as: BRADNER JAMES · BRADNER JAMES E · BRADNER JAMES ELLIOTT
53 granted patents·14 pending applications·703 citations·filing 2009–2024
98Inventor score
Files withDANA FARBER CANCER INST INC50BRADNER JAMES ELLIOTT3NOVARTIS AG3UNIV COLORADO STATE RES FOUND3CHILDRENS MEDICAL CT CORP2
Top patents by PatentIndex Score
67 records- 0198US10464925B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 5, 2019·36 cites·16 claims
- 0298US10125114B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2017·Granted Nov 13, 2018·57 cites·20 claims
- 0398US9821068B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2016·Granted Nov 21, 2017·71 cites·117 claims
- 0498US9770512B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2016·Granted Sep 26, 2017·63 cites·42 claims
- 0598US9750816B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2016·Granted Sep 5, 2017·62 cites·56 claims
- 0698US9714946B2Bromodomain binding reagents and uses thereofDANA FARBER CANCER INST INC·Filed 2014·Granted Jul 25, 2017·41 cites·13 claims
- 0798US9694084B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 4, 2017·76 cites·84 claims
- 0898US9320741B2Compositions and methods for treating neoplasia, inflammatory disease and other disordersDANA FARBER CANCER INST INC·Filed 2014·Granted Apr 26, 2016·23 cites·10 claims
- 0997US10669253B2Methods to induce targeted protein degradation through bifunctional moleculesDANA FARBER CANCER INST INC·Filed 2018·Granted Jun 2, 2020·17 cites·19 claims
- 1097US10407441B2Compositions and methods for treating neoplasia, inflammatory disease and other disordersDANA FARBER CANCER INST INC·Filed 2018·Granted Sep 10, 2019·10 cites·18 claims
- 1196US8981083B2Compositions and methods for treating neoplasia, inflammatory disease and other disordersBRADNER JAMES ELLIOTT·Filed 2011·Granted Mar 17, 2015·26 cites·6 claims
- 1293US11845728B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2021·Granted Dec 19, 2023·2 cites·24 claims
- 1393US9789120B2Male contraceptive compositions and methods of useDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 17, 2017·16 cites·26 claims
- 1492US10239888B2Targeted protein degradation using a mutant E3 ubiquitin ligaseDANA FARBER CANCER INST INC·Filed 2018·Granted Mar 26, 2019·18 cites·2 claims
- 1592US9301962B2Male contraceptive compositions and methods of useBRADNER JAMES ELLIOTT·Filed 2011·Granted Apr 5, 2016·23 cites·22 claims
- 1691US10934256B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2019·Granted Mar 2, 2021·4 cites·18 claims
- 1791US9695172B2Diazepane derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 4, 2017·13 cites·74 claims
- 1891US8217076B2Method for preparing largazole analogs and uses thereofWILLIAMS ROBERT M·Filed 2009·Granted Jul 10, 2012·20 cites·5 claims
- 1990US10464897B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2016·Granted Nov 5, 2019·4 cites·17 claims
- 2090US10150756B2Diaminopyrimidine benzenesulfone derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Dec 11, 2018·9 cites·19 claims
- 2189US10980808B2Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathiesCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Apr 20, 2021·4 cites·9 claims
- 2289US9506060B2LNA antisense oligonucleotides for the modulation of Myc expressionDANA FARBER CANCER INST INC·Filed 2013·Granted Nov 29, 2016·10 cites·20 claims
- 2388US10308653B2Diazepane derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2017·Granted Jun 4, 2019·8 cites·24 claims
- 2488US9975896B2Inhibitors of transcription factors and uses thereofDANA FARBER CANCER INST INC·Filed 2014·Granted May 22, 2018·17 cites·33 claims
- 2588US9815849B2Compositions and methods for treating leukemiaDANA FARBER CANCER INST INC·Filed 2013·Granted Nov 14, 2017·14 cites·13 claims
- 2687US10881668B2Acetamide thienotriazolodiazepines and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 5, 2021·4 cites·20 claims
- 2787US9186402B2Method for preparing largazole analogs and uses thereofUNIV COLORADO STATE RES FOUND·Filed 2013·Granted Nov 17, 2015·5 cites·11 claims
- 2886US11944625B2Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathiesCHILDRENS MEDICAL CT CORP·Filed 2021·Granted Apr 2, 2024·1 cites·17 claims
- 2986US9951074B2Dihydropteridinone derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 24, 2018·6 cites·19 claims
- 3085US9074009B2Stabilized MAML peptides and uses thereofBRADNER JAMES·Filed 2009·Granted Jul 7, 2015·16 cites·12 claims
- 3184US12441685B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2023·Granted Oct 14, 2025·0 cites·20 claims
- 3284US11578075B2Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2020·Granted Feb 14, 2023·1 cites·17 claims
- 3384US10793571B2Uses of diazepane derivativesDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 6, 2020·2 cites·20 claims
- 3482US10676484B2Compositions and methods for treating leukemiaDANA FARBER CANCER INST INC·Filed 2017·Granted Jun 9, 2020·2 cites·20 claims
- 3581US9763956B2Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapyBROAD INST INC·Filed 2013·Granted Sep 19, 2017·8 cites·12 claims
- 3681US8513290B2Method for preparing largazole analogs and uses thereofWILLIAMS ROBERT M·Filed 2012·Granted Aug 20, 2013·5 cites·9 claims
- 3780US11306105B2Cyano thienotriazolodiazepines and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Apr 19, 2022·3 cites·28 claims
- 3878US10730860B2Diaminopyrimidine benzenesulfone derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2018·Granted Aug 4, 2020·1 cites·22 claims
- 3975US11999802B2Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2018·Granted Jun 4, 2024·1 cites·33 claims
- 4074US10913752B2Bivalent bromodomain inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 9, 2021·1 cites·30 claims
- 4174US2023131952A1Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 4271US2020148702A1Compositions and methods for treating neoplasia, inflammatory disease and other disordersDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 4371US2024384007A1Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 4470US2025034126A1Chromobox protein inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 4569US10813939B2Bromodomain inhibitor as adjuvant in cancer immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Oct 27, 2020·1 cites·3 claims
- 4667US10676504B2Method for preparing largazole analogs and uses thereofUNIV COLORADO STATE RES FOUND·Filed 2016·Granted Jun 9, 2020·1 cites·12 claims
- 4766US11446309B2Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitorsDANA FARBER CANCER INST INC·Filed 2014·Granted Sep 20, 2022·0 cites·6 claims
- 4866US10538534B2Synthesis and utility of new capgroup largazole analogsUNIV COLORADO STATE RES FOUND·Filed 2016·Granted Jan 21, 2020·1 cites·18 claims
- 4962US11406645B2Acetamide thienotriazolodiazepines and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Aug 9, 2022·0 cites·21 claims
- 5061US2022119416A9Bivalent bromodomain inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →